[1]
S. Bošnjak, “Management of the adverse effects of immune checkpoint therapy”, arhfarm, vol. 72, no. Suppl. 4, pp. S39-S40, Oct. 2022, Accessed: Jul. 12, 2026. [Online]. Available: https://asistent.ceon.rs/index.php/arhfarm/article/view/38523